^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Esophageal Cancer |
| Drug: | cisplatin (DNA synthesis inhibitor) + paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Other Recommended Regimens…Paclitaxel with cisplatin or carboplatin.
